Kreon

Pancreas Powder, the active ingredient in Kreon, is a pancreatic enzyme replacement presented as an oral formulation for oral use. It aids patients with exocrine pancreatic insufficiency by supplying the digestive enzymes needed to break down fats, proteins, and carbohydrates.

GNH USA supplies Kreon as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company follows stringent quality standards and provides regulatory‑approved batches to meet global demand. Its distribution network ensures timely delivery to both private and public healthcare institutions across multiple continents.

Kreon is used in the management of disorders characterized by insufficient pancreatic enzyme production.

Exocrine pancreatic insufficiency: improves digestion of fats, proteins and carbohydrates, helping to alleviate malabsorption symptoms. Cystic fibrosis: provides the necessary pancreatic enzymes to support nutrient absorption in patients with pancreatic dysfunction. Chronic pancreatitis: supplements deficient endogenous enzymes, aiding in the breakdown of dietary nutrients and reducing steatorrhea.

Like other pancreatic enzyme preparations, Kreon may be associated with a range of adverse reactions.

Common Side Effects: - Abdominal discomfort - Flatulence - Diarrhea - Nausea - Oily or fatty stools

Serious or Rare Side Effects: - Allergic reactions including rash, itching or anaphylaxis - Severe abdominal pain or pancreatitis - Intestinal obstruction or blockage - Respiratory distress due to hypersensitivity

When prescribing Kreon, clinicians should consider several precautionary measures to ensure safe and effective use.

Dose individualisation: adjust the enzyme dose based on the patient’s clinical response and nutritional status. Monitoring nutritional status: regularly assess weight, fat‑soluble vitamin levels and stool fat content. Acid suppression therapy: concomitant use of proton pump inhibitors may be required to optimise enzyme activity. Allergy assessment: avoid use in patients with known hypersensitivity to porcine‑derived pancreatic extracts. Renal or hepatic impairment: use caution and consider dose modification in severe organ dysfunction. Store at ambient temperature below 25°C: keep in the original container, protect from moisture and light.

Kreon can interact with certain medicines that affect gastrointestinal pH or bind to enzymes, altering its efficacy.

Major Interactions (Avoid): - Bile acid sequestrants (e.g., cholestyramine, colestipol): bind pancreatic enzymes and markedly reduce their activity. - Antacids containing aluminum or magnesium: may interfere with enzyme absorption when taken simultaneously. - High‑dose proton pump inhibitors: may require dose adjustment of Kreon to maintain therapeutic effect.

Moderate Interactions (Monitor Closely): - Oral contraceptives: possible reduced absorption of estrogen components; monitor contraceptive efficacy. - Warfarin: monitor INR as changes in vitamin K absorption may affect anticoagulation. - Diabetes medications: altered carbohydrate digestion may affect glycemic control; adjust doses as needed. - Antibiotics such as tetracycline: may chelate with enzymes; observe for reduced efficacy.